Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 1999

View Archived Issues

Atugen and Roche Bioscience enter target validation collaboration

Radicicol derivative depletes Hsp90-associated molecules, exhibits antitumor activity

King Pharmaceuticals to acquire Lorabid from Lilly

GAD65 peptides prevent diabetes in mouse model

Inhibitex awarded SBIR grant to develop vaccine against drug-resistant infections

ROCK inhibitor Y-27632 affects ET-1-induced hypertrophy in rat cardiac myocytes

Ivax completes tender offer for outstanding shares of Galena

Genelabs Technologies: Q2 1999 highlights

Patent for wound healing technology patent awarded to BioSpecifics and Tufts

Merck launches COX-2 inhibitor in the U.K.

Corixa highlights collaborative agreements established in Q2 1999

Cangene to acquire Hyal

Promising troponin I analogue identified

Phase I trial begins for SMART 1D10 antibody in non-Hodgkin's B-cell lymphoma

First launch for bile acid-sequestering agent colestimide

Guilford and Amgen begin clinical testing of neuroimmunophilins

PDGFr-TK inhibitor prevents restenosis following angioplasty in minipigs

Diatide receives second major product approval in less than 12 months

NIH researchers identify potential clue to the prevention of prion diseases

U.K.'s MCA is first to approve Synercid for marketing

Indian academic team identifies interesting new antibacterial compounds

Novel AMPA/NMDA antagonists discovered at Rhone-Poulenc Rorer

INSERM describes TPP II inhibitors and their use in treating eating disorders, obesity

SB team identifies bone resorption inhibitors selective for mammalian osteoclasts

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...